Remove 2017 Remove Clinical Trials Remove Conditions Remove Epilepsy
article thumbnail

Cannabis: Good or Bad for Human Health  

Cannabis Law Report

Over the years, research has generated results to suggest that marijuana benefits in the treatment of some conditions. The drug for treating such conditions involves a purified form of CBD. The approval is based on the research and clinical trials. Let us have a look at those. Chronic pain. CBD occurs in cannabis.

article thumbnail

A Patient’s Guide to CBD and Drug Interactions

Healer

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . CBD and Immunosuppressant Medications.

CBD 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why People Choose THC Oil: Its Benefits and Effects

Cannabis Law Report

For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. Clinical trials are also underway to determine the possibility of THC, cannabis, and other cannabinoids to help with obesity and appetite. That’s why some people choose THC oil.

Oil 104
article thumbnail

A Patient’s Guide to CBD and Drug Interactions

Healer

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. [2]. CBD and Immunosuppressant Medications.

CBD 52
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52
article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.